Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Oligodendroglioma 2Neuroblastoma 2Glioblastoma 2Astrocytoma 2Sezary Syndrome 1Rhabdomyosarcoma 1Recurrence 1Osteosarcoma 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Neuroepithelial 1Mycosis Fungoides 1Lymphoproliferative Disorders 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Intraocular Lymphoma 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Hepatoblastoma 1Gliosarcoma 1Ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1Brain Stem Neoplasms 1

Interventions

Vincristine 2Specimen Handling 2Gene Expression Profiling 2Fluorouracil 2Cisplatin 2Carboplatin 2sodium thiosulfate 1imetelstat 1dehydroftorafur 1X-Rays 1Watchful Waiting 1Sorafenib 1Restraint, Physical 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Platinum 1Phantoms, Imaging 1Oxaliplatin 1Observation 1Microarray Analysis 1MLN 8237 1Irinotecan 1Gene Rearrangement 1Gemcitabine 1GRN163L peptide 1Etoposide 1Doxorubicin 1Cytogenetic Analysis 1Bone Density 1Base Sequence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Hepatoblastoma × imetelstat × Clear all
NCT02011126 2018-08-07

Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Children's Oncology Group

Phase 2 Withdrawn
CNSGastrointestinalSarcoma

Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡